跳至主要内容
临床试验/EUCTR2015-003779-31-ES
EUCTR2015-003779-31-ES进行中(未招募)不适用

Prospective, Randomized Open Trial to Evaluate the Efficacy of Highly Purified Urinary FSH (Fostipur®, IBSA) versus Recombinant FSH (Bemfola® Finox) in Oocyte Donors Undergoing Controlled Ovarian Stimulation Based on Receptor N680S FSH Gene Polymorphism - Genodon Trial

INSTITUTO BERNABE0 个研究点开始时间: 2015年10月30日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Be considered apt to get into the oocyte donation program of Instituto Bernabeu
  • Age between 18 and 30 years
  • Body Mass Index over 18 and under 28
  • Antral follicle count greater than 9 and less than 25 (adding both ovaries)
  • Patients starting ovarian stimulation with 225 IU of FSH
  • Presence of both ovaries
  • Ability to participate and comply with the study protocol
  • Signing the written consent form
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 180
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Not suitable for inclusion in the oocyte donation program of Institute Bernabeu.
  • Concurrent participation in another study

研究者

发起方
INSTITUTO BERNABE

相似试验